Hyper-Collaboration in Life Sciences Creates Supply Chain Opportunities
Logility
NOVEMBER 11, 2021
From repurposed therapies to novel vaccines, the normal timeline of R&D has been accelerated beyond measure.” — Dr. Steve Arlington, president of The Pistoia Alliance. The consortium model alone saw a nine-fold increase between 2005 and 2014 versus the prior decade, with 334 new consortia formed, versus just 34 from 1995 to 2004.
130 
Let's personalize your content